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doi:10.1016/j.ejvs.2009.06.016Abstract Objective: To evaluate the feasibility and efficacy of simultaneous combined endo-
vascular and open lower extremity arterial reconstruction.
Design: Case series study with retrospective analysis of prospectively collected non-
randomised data.
Methods: Patients were divided into three groups: group 1 and group 2 included patients who
underwent endovascular reconstruction proximal and distal to the site of open reconstruction,
respectively, whereas group 3 included patients who underwent open surgery with both prox-
imal and distal endoluminal procedures. Patency analyses were performed using KaplaneMeier
life tables. Univariate and multivariate analyses were used to assess the influence of various
risk factors on primary patency.
Results: Complete data were obtained from 60 patients who underwent 61 single-step hybrid
procedures. Technical and haemodynamic success rates were 100% and 95%, respectively. The
perioperative mortality rate was 3%. The primary and assisted-primary patency rates at 12
months were 71% and 98%, respectively. Primary patency rates were lower in group 3 when
compared with groups 1 and 2 (log-rank test, pZ 0.006). The presence of diabetes and dysli-
pidaemia were independent predictors of decreased primary patency (pZ 0.003 and
pZ 0.014, respectively).
Conclusions: Hybrid procedures provide an effective treatment management of selected
patients with multilevel lower extremity arterial disease. The extent of the disease, diabetes
and dyslipidaemia are associated with worse outcome.
ª 2009 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.10 670042.
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Hybrid Endovascular and Open Treatment 617Peripheral atherosclerotic arterial disease is commonly
associated with a multilevel pattern of occlusive disease,
especially in patients with critical limb ischaemia.1
Optimum results may be achieved with both inflow and
outflow arterial reconstruction. Treatment strategies for
multisegment disease include either extensive operative
procedures or a combination of endovascular techniques
and open vascular surgery, performed in a single or multiple
settings. The incorporation of imaging and endovascular
inventory into the standard operative armamentarium and
the ever-increasing levels of vascular surgeons’ expertise in
endoluminal techniques have broadened the scope of
management of peripheral arterial disease, allowing less-
invasive therapeutic options tailored to the needs of these
high-risk surgical patients. Simultaneous hybrid endovas-
cular and open lower extremity arterial reconstructive
procedures have the advantages of obviating the need for
major surgery and avoiding separate staged interventions
and their associated morbidity. They may, therefore,
expand the potentials of both approaches for the
management of the critically ischaemic limb. There are
published results of several types of combined treatment of
various patterns of iliac, femoral and infrapopliteal
diseases with promising outcomes.2e20
This study was conducted to assess the efficacy of hybrid
lower limb arterial reconstruction in patients with critical
or severe lower limb ischaemia.
Methods
Study design
A non-randomised retrospective study was undertaken
including all patients who had obstructive arterial disease
in at least two levels among the iliac, inguinal (including
the common femoral, femoris profunda and the origin of the
superficial femoral artery), femoro-popliteal (including
the superficial femoral and the supra-genicular part of
the popliteal artery), and infra-genicular levels, and were
treated with a combination of endovascular and open
arterial reconstructive procedures. These procedures
were performed on the same occasion for each patient at
a single centre. This type of study did not require the
approval of the Institutional Review Board, and all
patients provided informed consent before treatment.
Patients and data collection
Patients were selected for treatment on the basis of the
presence of symptomatic lower extremity peripheral arte-
rial disease as defined by the ‘‘recommended standards for
reports dealing with lower extremity ischemia.’’21 Patients
who presented emergently with acute lower limb ischaemia
in the presence of peripheral arterial disease were also
included in the study. Preoperative, intra-operative and
follow-up information was available for all patients, and it
was prospectively collected and retrospectively reviewed
from computer-based data, hospital charts, operative and
outpatient records and telephone communication with
patients or their relatives. Demographic data and risk
factors for arteriosclerosis were collected. Previousipsilateral lower limb re-vascularisation procedures were
also recorded. All patients underwent preoperative
peripheral arterial evaluation with physical examination,
measurement of ankleebrachial pressure index (ABPI), and
either duplex ultrasonography, digital subtraction angiog-
raphy or computed tomography angiography. Rutherford
classification was used to determine clinical category at the
time of presentation as specified by the Society for Vascular
Surgery/American Association for Vascular Surgery report-
ing standards.21
Re-vascularisation procedures
The same team of vascular surgeons with special interests
in endovascular surgery selected the patients deemed
suitable for hybrid lower limb arterial reconstruction, and
carried out all the procedures. These procedures were
performed in the operating room equipped with a moveable
radiolucent surgical table and a mobile digital angiographic
system using a C-arm (Philips BV Endura, Philips Medical
Systems, Release 2.2.3, the Netherlands). The patients
included in the study were divided into three groups
according to the type of re-vascularisation procedures:
group 1 included patients who underwent endovascular
reconstruction proximal to the site of open reconstruction,
group 2 included patients with endoluminal procedures
distal to the site of open surgery and group 3 included
patients who underwent open arterial reconstruction with
both proximal and distal endovascular procedures.
Iliac and femoro-popliteal lesions were defined
according to the TransAtlantic InterSociety Consensus II
(TASC II).22 In the iliac area, TASC A lesions were treated
with angioplasty alone, whereas TASC B and TASC C lesions
as well as complicated or unsuccessful angioplasty were
treated with stent implantation. Open arterial reconstruc-
tion was the treatment of choice for TASC D iliac lesions. In
the femoro-popliteal area, endovascular reconstruction
was used for the treatment of TASC A through TASC C
lesions. In these lesions angioplasty alone was preferred,
with stenting being reserved when the angiographic result
was inadequate, such as dissection or elastic wall recoil.
TASC D femoralepopliteal disease was treated with either
remote superficial femoral artery endarterectomy or open
surgical reconstruction (bypass). The type of endoluminal
reconstruction (angioplasty with or without stenting/
grafting), the choice of endoluminal device and the type of
open surgical reconstruction were at the discretion of the
operating surgeon.
For the assessment of the degree of stenosis at the iliac
segment, oblique images and catheter pressure measure-
ments were made whenever the severity of stenosis was
questionable. Significant stenosis requiring treatment was
defined as that causing more than 50% luminal reduction
and pressure drop of more than 15 mmHg.
The procedures were performed under local or regional
(i.e., spinal and epidural) anaesthesia at the discretion of
the treating physicians. At the beginning of the procedure,
100 UI kg1 of standard unfractionated heparin was
administered. Typically, the ipsilateral femoral bifurcation
was exposed through a longitudinal inguinal incision. The
open arterial reconstruction preceded upwards or down-
wards endovascular re-vascularisation in all patients; the
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sheath was placed either through the anastomotic suture
line prior to placement of the last stitch or through direct
puncture of the prosthetic material (patch or graft). The
contralateral common femoral artery was percutaneously
catheterised if a kissing balloon angioplasty technique at
the aortic bifurcation was required. At the end of the
procedure, angiography was performed through a 5 Fr to 7
Fr arterial sheath.
Postoperative follow-up
All patients underwent a postoperative surveillance pro-
gramme, which consisted of clinical examination, ABPI
measurement and colour duplex ultrasonography at 1, 3
and 6 months and at 6-month intervals thereafter. Patients
with worsening clinical symptoms, physical examinations
and/or non-invasive studies were further assessed with
digital subtraction angiography or computer-assisted arte-
riography. The decision on the type of re-intervention was
made by the treating surgeon.
Definitions and end-points
Technical success was defined as residual stenosis of less
than 30% as demonstrated on intra-operative arteriography.
Haemodynamic success was defined as an increase in the
ABPI by more than 0.1, according to the reporting stan-
dards.21 According to the same reporting standards docu-
ment,21 clinical improvement was defined as an upward
shift by at least one clinical Rutherford category, except
when actual tissue loss existed, in which case there should
be moving up of at least two categories. Perioperative
morbidity and mortality included complications and death
occurring within 30 days from surgical intervention. In this
study, patency refers to the status of the reconstructed
arterial segments. Patients with rest pain or tissue loss
(Rutherford category 4 or 5) and those with acutely
ischaemic limbs were used to determine the limb-salvage
rates.
Statistical analysis
Statistical analysis was performed with a computer-based
statistical software package (SPSS 15 for Windows, SPSS
Inc., Chicago, IL, USA). Patency and limb-salvage analyses
were performed using the KaplaneMeier life table
method. Differences in patency rates were determined
with the log-rank test. The chi-square (c2) test was used
to evaluate the differences between the groups of
patients for categorical variables (c2 for independent
groups, two-tailed p value). Continuous variables were
analysed with the ManneWhitney U test for unpaired
comparisons. Cox proportional hazards model was used for
multivariate analysis to assess the influence of various risk
factors on primary patency. A univariate model was fit for
each covariate and the significant predictors at level
p1Z 0.20 were identified. These were used in a multivar-
iate model and backward selection was applied to elimi-
nate non-significant variables at level p2Z 0.10. The
formerly non-significant covariates were then consideredagain using forward selection at level p3Z 0.10. Final
pruning of main-effects model was carried out using
stepwise regression with significance level p4Z 0.05.
Interactions between the main effects of the final model
were examined. Differences in the ABPI were analysed
using the paired Student’s t-test. Statistical significance
was assumed for a p value< 0.05.
Results
Patients and procedures
Complete data were obtained from 60 patients who
underwent 61 single-step combined open and endovascular
reconstruction of multilevel peripheral arterial disease.
Demographic and clinical features of the study groups are
shown in Table 1. The mean age of the whole study pop-
ulation was 69 years (range: 50e87 years) with a male
predominance (51 males, 84%). The most commonly asso-
ciated cardiovascular risk factors were hypertension (75%),
smoking (59%), dyslipidaemia (49%), coronary artery
disease (43%) and diabetes (31%). According to the
Rutherford grading, 26 patients (43%) were treated for
severe intermittent claudication (Rutherford category 3),
14 patients (23%) had persistent rest pain (Rutherford
category 4) and 15 patients (24%) had minor tissue loss
(Rutherford category 5). In another six patients (10%) the
indication for arterial reconstruction was acute ischaemia
in the presence of underlying peripheral arterial disease.
No patients with moderate intermittent claudication
(Rutherford category 2) or major tissue loss/gangrene
(Rutherford category 6) were treated. Eleven patients
(18%) had previously undergone ipsilateral lower limb
arterial reconstruction. No statistically significant differ-
ences in the demographic characteristics and clinical
presentation among the groups of patients were found
(Table 1).
The frequency of the open and endovascular procedures
performed in the three groups are presented in Table 2.
Group 1 comprised 28 limbs, group 2 comprised 24 limbs
and group 3 included 9 limbs (Tables 1 and 2). The most
common open procedure was endarterectomy of the
femoral bifurcation and patch arterioplasty, which was
performed in 42 limbs, followed by femoro-femoral cross-
over bypass in nine patients, and femoro-popliteal and
femoro-distal bypasses in five and two limbs, respectively.
Thrombectomy was performed in five cases of acute
ischaemia in the presence of previous arterial reconstruc-
tion or lower limb arterial occlusive disease. Endovascular
procedures included angioplasty, stenting or stent graft
deployment in the arterial axes upward and/or downward
the site of open surgery. Angioplasty of the infra-popliteal
arteries was performed in six limbs, whereas in one patient
one drug-eluting stent was implanted in the infra-genicular
area. Remote endarterectomy of the superficial femoral
artery was performed in 10 patients as part of the
combined hybrid arterial reconstructions. The majority
(90%) of these hybrid procedures were performed under
either spinal or epidural anaesthesia, whereas local
anaesthesia was used in six cases. The median post-inter-
vention hospital stay was 3 days (range, 1e35 days).
Table 1 Patient characteristics.
Characteristic Group 1 Group 2 Group 3 p
Number of limbs 28 24 9 e
Mean age (years) 69 (range, 50e86) 71 (range, 56e87) 65 (range, 50e79) ns
Sex (male,female) 21 (75%), 7 (25%) 21 (87%), 3 (13%) 9 (100%), 0 (0%) ns
HTN 20 (71%) 17 (71%) 9 (100%) ns
DM 7 (25%) 7 (29%) 5 (56%) ns
CAD 13 (46%) 11 (46%) 2 (22%) ns
Dislipidaemia 14 (50%) 11 (46%) 5 (56%) ns
Smoking 14 (50%) 17 (71%) 5 (56%) ns
Claudication 11 (39%) 12 (50%) 3 (33%) ns
Rest pain 8 (29%) 3 (12%) 3 (33%) ns
Tissue loss 8 (29%) 4 (17%) 3 (33%) ns
Acute ischaemia 1 (3%) 5 (21%) 0 (0%) ns
Previous ipsilateral
arterial procedure
4 (14%) 4 (17%) 3 (33%) ns
HTN, hypertension; DM, diabetes mellitus; CAD, coronary artery disease; ns, not signifficant.
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Technical success was achieved in all patients (100%). Mean
ABPI increased significantly from 0.34 preoperatively to
0.72 after re-vascularisation (p< 0.05). The mean ABPI
increase was 0.40. Two out of the 19 diabetic patients had
incompressible arteries, which excluded them from mean
ABPI calculations. For the entire study population, a hae-
modynamic success rate of 95% was found. Perioperative
complications occurred in 22 patients, yielding a complica-
tion rate of 36%. Infective complications, either local or
systemic, occurred in six patients (10%), cardiac compli-
cations (myocardial infarction, cardiac failure) affected
five patients (8%) and acute renal failure occurred in two
patients (3%). Temporary renal failure occurred in one
patient with long-standing diabetes and mild renalTable 2 Types of open and endovascular procedures.
Group
1
Group
2
Group
3
Open procedure
Femoral bifurcation endarterectomy 17 19 6
Femoro-femoral crossover bypass 8 e 1
Femoro-popliteal bypass 2 2 1
Femoro-distal bypass 2 e e
Thrombectomy of bypass graft/SFA 1 4 e
Endovascular procedure
TA/stent CIA/EIA 25 e 9
TA/stent graft CIA/EIA 3 e e
TA SFA/popliteal art. e 4 2
TA/stent SFA/popliteal art. e 10 3
TA/stent graft SFA/popliteal art. e 4 1
TA infragenicular arteries e 4 2
RSFAE e 7 3
TA PFA 1 e e
SFA, superficial femoral artery; CIA, common iliac artery; EIA,
external iliac artery; RSFAE, remote superficial femoral artery
endarterectomy; TA, transluminal angioplasty.derangement preoperatively and in another with no
evidence on renal impairment on preoperative diagnostic
work-up; the cause of renal failure was assumed to be
contrast-induced in both patients. Other complications
included femoral nerve palsy, lymphorrhoea/lympho-
oedema, arterial ruptureehaematoma, stroke and heparin-
induced thrombocytopaenia. These complications were
successfully managed with appropriate medical treatment
except from two patients who died from myocardial
infarction on the 3rd and 26th postoperative day, respec-
tively, resulting in 3% perioperative mortality. Two ampu-
tations were performed in the immediate postoperative
period; one resulted from ongoing septic gangrene in
a limb, which had been successfully re-vascularised, but
there were life-threatening signs of systemic sepsis. The
second amputation was performed on the 7th postoperative
day in an acutely ischaemic limb in which attempts at re-
vascularisation were unsuccessful.
Outcome on follow-up
The median follow-up period was 10.5 months (range, 1e36
months); if patients suffered perioperative death or
amputation were excluded. Clinical improvement was
achieved in all but four patients (93%). Failure to improve
resulted in amputation in two of these patients. Primary,
assisted-primary and secondary patency rates at 12 months
were 71%, 98% and 98%, respectively (Fig. 1). Primary
patency rates were lower in group 3 as compared with
groups 1 and 2 (KaplaneMeier analysis, log-rank test,
pZ 0.006) (Fig. 2). The five primary failures occurred at 1,
3, 5, 8 and 10 months after the initial hybrid arterial
reconstruction and were treated with endovascular inter-
ventions (Table 3). No patient having undergone endarter-
ectomy of the femoral bifurcation and patch arterioplasty
failed to retain their patency at that segment during the
follow-up period. Thirty-five limbs with rest pain, tissue
loss and acute ischaemia were evaluated for limb salvage,
and a limb-salvage rate of 90% at 6 months was found
(Fig. 3). Cox regression analysis revealed that the presence
of diabetes and dyslipidaemia were independent predictors
Figure 1 Overall primary, assisted primary and secondary
patency (Kaplan-Meier analysis).
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respectively). No additional factors, among age, sex,
hypertension, current smoking, previous ipsilateral arterial
reconstruction, limb salvage or perioperative complica-
tions, were found to affect primary patency. An overall
amputation rate of 5% (three limbs) was recorded up to the
end of follow-up. Beyond the perioperative period and up
to the end of follow-up, five patients died: three ofFigure 2 Primary patency rates were lower in group 3
compared with groups 1 and 2 (Kaplan-Meier analysis, log-rank
test, pZ 0.006).myocardial infarction, one of stroke and another of
pulmonary embolism.Discussion
Multilevel atherosclerotic arterial disease affecting the
lower extremities requires complex treatment strategies,
which involve inflow and outflow arterial reconstructions,
in order to provide patients with adequate clinical
improvement. Conventional open surgical management of
such lesions consists of extensive re-vascularisation proce-
dures. However, multisegmental arterial disease is
frequently associated with significant co-morbidities and
critical lower extremity ischaemia, categorising these
patients as high risk for major operative procedures. This
has prompted the adoption of less-invasive interventions.
This study presents alternative hybrid open and endo-
luminal approaches to the management of multilevel lower
extremity atherosclerotic arterial disease. Our study pop-
ulation comprises 60 patients with significant co-morbid
risk factors (Table 1). Furthermore, more than half of the
patients (57%) were operated on for limb salvage, pre-
senting with rest pain, tissue loss or acutely ischaemic leg
at risk for limb loss. These patients were carefully selected
for simultaneous combined open and endovascular inter-
ventions, taking into account the operative risk, potential
for clinical improvement and patterns of segmental arterial
disease. Standard conventional surgery would require
extensive re-vascularisation procedures, which were
deemed to expose our study population to unreasonably
high surgical risks.
Technical aspects and operative details of using endo-
luminal methods in conjunction with standard open
procedures to manage multisegmental arterial occlusive
disease have been described.23e25 Epidural or spinal
anaesthesia was preferred over general anaesthesia by the
attending anaesthesiologists to avoid complications asso-
ciated with general anaesthesia in these high-risk patients
with a significant proportion of smoking history and coro-
nary artery disease. A small proportion of patients (10%)
received local anaesthesia. Several combinations of open
and endovascular procedures were used, which were cat-
egorised into three types for practical and grouping
purposes. In particular, group 3 comprised patients who
received hybrid re-vascularisation of the whole lower
extremity arterial axis, from the iliac up to the infra-
popliteal level in many patients. The simultaneous rather
than staged approach allowed easy access to the proximal
and/or distal arterial beds for endovascular intervention,
obviated the risks of post-puncture haemorrhage or failed
percutaneous access and avoided prolonged hospitalisation
and surgical delays.
In our series, immediate technical and haemodynamic
success rates of 100% and 95%, respectively, were achieved,
confirming the immediate efficacy of this combined
approach. Even though our results in terms of patency rates
are difficult to be directly compared with those of either
extensive open re-vascularisation procedures for multilevel
arterial disease or hybrid procedures, they seem to
be comparable with the outcomes of other combined
re-vascularisation series.2e20 The patients underwent
Table 3 Primary failures and their management.
Initial open procedure Initial endovascular procedure Failure Reintervention
Femoral bifurcation endarterectomy,
patch arterioplasty
RSFAE 5 mo TA/stent graft popliteal
Femoro-femoral crossover bypass R-L TA/stenting R CIA, RSFAE L 8 mo TA/stent graft R CIA
Femoral bifurcation endarterectomy,
patch arterioplasty
TA/stenting EIA, RSFAE 3 mo TA/stent graft SFA
Femoral bifurcation endarterectomy,
patch arterioplasty
TA/stenting CIA, TA/stenting SFA, TA peroneal 1 mo TA/stenting CIA
Femoral bifurcation endarterectomy,
patch arterioplasty
TA/stenting CIA/EIA, TA/stent graft SFA 10 mo TA/stenting SFA
RSFAE, remote superficial femoral artery endarterectomy; TA, transluminal angioplasty; CIA, common iliac artery; EIA, external iliac
artery; SFA, superficial femoral artery; R, right ; L, left.
Hybrid Endovascular and Open Treatment 621a surveillance programme, which allowed early detection
of clinical and haemodynamic deterioration. Primary fail-
ures were successfully managed with percutaneous trans-
luminal interventions (Table 3). Closer surveillance might
be warranted for patients with diabetes and dyslipidaemia,
as these factors were found to be predictors of decreased
primary patency.
Despite the small numbers of our series, in-between
group analysis and comparisons were attempted. It was
found that group 3 had worse outcome in terms of primary
patency as compared with the other two groups. This might
be interpreted by the fact that this group reflects more
extensive and severe atherosclerotic disease, which would
be associated with poor outcome. Furthermore, more
extensive intervention is performed at multiple segments,
which increases the likelihood of failure of primary
patency. This observation has been reported in other
studies in which multisegment disease was an independent
risk factor for the outcomes after transluminal angio-
plasty.26e28
Potential limitations to our study are its retrospective
nature and the absence of a control group to compare the
outcomes of hybrid treatment with. Another shortcoming is
the heterogeneous nature of our study population; the
patients included in the study had different patterns ofMonths
40,0030,0020,0010,000,00
L
i
m
b
 
s
a
l
v
a
g
e
1,0
0,8
0,6
0,4
0,2
0,0
Figure 3 Cumulative limb salvage after hybrid lower
extremity arterial reconstruction (Kaplan-Meier analysis).lower extremity arterial disease and were subjected to
various arterial reconstructive procedures. In addition, the
follow-up period was relatively short.
Conclusions
Hybrid open and endovascular procedures performed at
a single setting provide an effective treatment of multilevel
lower extremity atherosclerotic arterial disease. Our data
suggest that the immediate results, expressed as technical
and haemodynamic success and the mid-term outcomes,
represented by the patency and limb-salvage rates, are
satisfactory. More extensive disease and interventions,
diabetes and dyslipidaemia were found to be associated
with worse outcome. Hybrid procedures for the treatment
of severe lower extremity arterial disease may provide less-
invasive therapeutic options tailored to the needs of high-
risk patients.
Conflict of Interest/Funding
None.
References
1 Haimovici H, Steinman C. Aortoiliac angiographic patterns
associated with femoropopliteal occlusive disease: significance
in reconstructive arterial surgery. Surgery 1969;65(2):232e40.
2 Griffith CD, Harrison JD, Gregson RH, Makin GS, Hopkinson BR.
Transluminal iliac angioplasty with distal bypass surgery in
patients with critical limb ischaemia. J R Coll Surg Edinb 1989;
34(5):253e5.
3 Cle´ment C, Costa-Foru B, Vernon P, Nicaise H. Transluminal
angioplasty performed by the surgeon in lower limb arterial
occlusive disease: one hundred fifty cases. Ann Vasc Surg 1990;
4(6):519e27.
4 Wilson SE, White GH, Wolf G, Cross AP. Proximal percutaneous
balloon angioplasty and distal bypass for multilevel arterial
occlusion. Veterans administration cooperative study no. 199.
Ann Vasc Surg 1990;4(4):351e5.
5 van der Vliet JA, Mulling FJ, Heijstraten FM, Reinaerts HH,
Buskens FG. Femoropopliteal arterial reconstruction with intra-
operative iliac transluminal angioplasty for disabling claudication:
results of a combined approach. Eur J Vasc Surg 1992;6(6):607e9.
6 Demasi RJ, Snyder SO, Wheeler JR, Gregory RT, Gayle RG,
Parent FN, et al. Intraoperative iliac artery stents: combination
622 G.A. Antoniou et al.with infra-inguinal revascularization procedures. Am Surg 1994;
60(11):854e9.
7 Lopez-Galarza LA, Ray LI, Rodriguez-Lopez J, Diethrich EB.
Combined percutaneous transluminal angioplasty, iliac stent
deployment, and femorofemoral bypass for bilateral aortoiliac
occlusive disease. J Am Coll Surg 1997;184(3):249e58.
8 Lau H, Cheng SW. Intraoperative endovascular angioplasty and
stenting of iliac artery: an adjunct to femoro-popliteal bypass. J
Am Coll Surg 1998 Apr;186(4):408e15.
9 Hamilton Jr IN, Mathews JA, Sailors DM, Woody JD, Burns RP.
Combination endovascular and open treatment of peripheral
arterial occlusive disease performed by surgeons. Am Surg 1998
Jun;64(6):581e92.
10 Melliere D, Cron J, Allaire E, Desgranges P, Becquemin JP.
Indications and benefits of simultaneous endoluminal balloon
angioplasty and open surgery during elective lower limb
revascularization. Cardiovasc Surg 1999;7(2):242e6.
11 Siskin G, Darling 3rd RC, Stainken B, Chang BB, Paty PS,
Kreienberg PB, et al. Combined use of iliac artery angioplasty
and infrainguinal revascularization for treatment of multilevel
atherosclerotic disease. Ann Vasc Surg 1999;13(1):45e51.
12 Aburahma AF, Robinson PA, Cook CC, Hopkins ES. Selecting
patients for combined femorofemoral bypass grafting and iliac
balloon angioplasty and stenting for bilateral iliac disease. J
Vasc Surg 2001;33(2 Suppl):S93e9.
13 Timaran CH, Stevens SL, Freeman MB, Goldman MH. Infrain-
guinal arterial reconstructions in patients with aortoiliac
occlusive disease: the influence of iliac stenting. J Vasc Surg
2001;34(6):971e8.
14 Schneider PA, Caps MT, Ogawa DY, Hayman ES. Intraoperative
superficial femoral artery balloon angioplasty and popliteal to
distal bypass graft: an option for combined open and endovas-
cular treatment of diabetic gangrene. J Vasc Surg 2001;33(5):
955e62.
15 Nelson PR, Powell RJ, Schermerhorn ML, Fillinger MF,
Zwolak RM, Walsh DB, et al. Early results of external iliac artery
stenting combined with common femoral artery endarterec-
tomy. J Vasc Surg 2002;35(6):1107e13.
16 Dougherty MJ, Young LP, Calligaro KD. One hundred twenty-five
concomitant endovascular and open procedures for lower
extremity arterial disease. J Vasc Surg 2003;37(2):316e22.
17 Timaran CH, Ohki T, Gargiulo 3rd NJ, Veith FJ, Stevens SL,
Freeman MB, et al. Iliac artery stenting in patients with poordistal runoff: influence of concomitant infrainguinal arterial
reconstruction. J Vasc Surg 2003;38(3):479e85.
18 Cotroneo AR, Iezzi R, Marano G, Fonio P, Nessi F, Gandini G.
Hybrid therapy in patients with complex peripheral multifocal
steno-obstructive vascular disease: two-year results. Cardiovasc
Intervent Radiol 2007;30(3):355e61.
19 Chang RW, Goodney PP, Baek JH, Nolan BW, Rzucidlo EM,
Powell RJ. Long-term results of combined common femoral
endarterectomy and iliac stenting/stent grafting for occlusive
disease. J Vasc Surg 2008 Aug;48(2):362e7.
20 Lantis J, Jensen M, Benvenisty A, Mendes D, Gendics C, Todd G.
Outcomes of combined superficial femoral endovascular
revascularization and popliteal to distal bypass for patients
with tissue loss. Ann Vasc Surg 2008;22(3):366e71.
21 Rutherford RB, Baker JD, Ernst C, Johnston KW, Porter JM,
Ahn S, et al. Recommended standards for reports dealing with
lower extremity ischemia: revised version. J Vasc Surg 1997;
26(3):517e38.
22 Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA,
Fowkes FG. TASC II working group. Inter-society consensus for
the management of peripheral arterial disease (TASC II). J Vasc
Surg 2007;45(Suppl. S):S5e67.
23 Reed AB. Endovascular as an open adjunct: use of hybrid
endovascular treatment in the SFA. Semin Vasc Surg 2008;21(4):
200e3.
24 Schneider PA. Iliac angioplasty and stenting in association with
infrainguinal bypasses: timing and techniques. Semin Vasc Surg
2003;16(4):291e9.
25 Schneider PA. Balloon angioplasty and stent placement during
operative vascular reconstruction for lower extremity ischemia.
Ann Vasc Surg 1996;10(6):589e98.
26 Kudo T, Chandra FA, Ahn SS. The effectiveness of percutaneous
transluminal angioplasty for the treatment of critical limb
ischemia: a 10-year experience. J Vasc Surg 2005;41(3):
423e35.
27 Powell RJ, Fillinger M, Walsh DB, Zwolak R, Cronenwett JL.
Predicting outcome of angioplasty and selective stenting of
multisegment iliac artery occlusive disease. J Vasc Surg 2000;
32(3):564e9.
28 Powell RJ, Fillinger M, Bettmann M, Jeffery R, Langdon D,
Walsh DB, et al. The durability of endovascular treatment of
multisegment iliac occlusive disease. J Vasc Surg 2000;31(6):
1178e84.
